Latest News about REGN
Recent news which mentions REGN
From Benzinga
Tickers
REGN
From Motley Fool
Exicure Shares Interim Cavrotolimod Data From Early-Stage Trial In Solid Tumor Patients
August 05, 2021
From Benzinga
What Will the Stock Market Do Today? 3 Big Stories to Watch.
August 05, 2021
From InvestorPlace
Delta, Lambda Covid Variants Still Weighing On Market Despite Positive Earnings Reports
August 05, 2021
From Benzinga
Sanofi - Regeneron's Libtayo/Chemo Treatment Improves Overall Survival First-Line Lung Cancer
August 05, 2021
From Benzinga
Regeneron Beats Street Estimates Big In Q2 As COVID-19 Antibody Boosts Topline, Cuts FY21 R&D Spend Outlook
August 05, 2021
Tickers
REGN
From Benzinga
From Motley Fool
10 Biggest Price Target Changes For Monday
August 02, 2021
From Benzinga
FDA Approves Regeneron - Roche's COVID-19 Antibody Cocktail For Post-Exposure Prophylaxis
August 02, 2021
From Benzinga
Videogames entered the mainstream in the pandemic, but the industry faces a rough transition
August 01, 2021
From MarketWatch
Is a Meltdown on the Way for Moderna Stock?
July 30, 2021
From Motley Fool
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
From Benzinga
Regeneron - Sanofi's Dupixent Improves Itch, Hives In Inflammatory Skin Disease Patients
July 29, 2021
From Benzinga
Is This Mid-Cap Biotech Stock a Buy Now?
July 29, 2021
From Motley Fool
3 Things About Regeneron That Smart Investors Know
July 29, 2021
From Motley Fool
From Motley Fool
From Benzinga
Sanofi-Regeneron's COPD Drug Fails In Mid-Stage Trial, But Shows Potential Benefit In Subgroup of Former Smokers
July 22, 2021
From Benzinga
From Motley Fool
AMD And Biogen Lead The QQQ Lower Thursday
July 15, 2021
From Benzinga
5 French Stocks To Consider For Bastille Day
July 14, 2021
From Benzinga
5 Stocks to Own for the Surge in Coronavirus Variants
July 14, 2021
From Motley Fool
Is This Coronavirus Stock Undervalued?
July 14, 2021
From Motley Fool
3 Top Biotech Stocks to Buy in July
July 11, 2021
From Motley Fool
Is It Too Late to Buy Intellia Therapeutics?
July 10, 2021
From Motley Fool
Why ASLAN Pharmaceuticals Blasted Higher on Friday
July 09, 2021
From Motley Fool
Why Beam Therapeutics Climbed 64.5% in June
July 08, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
